MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors

Cancer

Volumn 92, Issue 11, 2001, Pages 2778-2785

  Aubry, Florence ^a   Satie, Anne Pascale ^a   Rioux Leclercq, Nathalie ^b   Rajpert De Meyts, Ewa ^c   Spagnoli, Giulio C ^d,e   Chomez, Patrick ^f   De Backer, Olivier ^f   Jégou, Bernard ^a   Samson, Michel ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Carcinoma in situ; Germ cell neoplasms; MAGE; Seminoma; Testis

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; EMBRYO; FETUS; GENE; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEMINOMA; TESTIS TUMOR;

ANTIGENS, NEOPLASM; GONADS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; PROGNOSIS; TESTICULAR NEOPLASMS; TESTIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035576197     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011201)92:11<2778::AID-CNCR10125>3.0.CO;2-S     Document Type: Article

References (47)

1. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982
2. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology
3. Testicular cancer in nine northern European countries
4. A new classification of germ cell tumours of the testis
5. Possible carcinoma-in-situ of the testis
6. The spermatocytic seminoma: Views on pathogenesis
7. T cell defined tumor antigens
8. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
9. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
10. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
11. Isolation and characterization of a MAGE gene family in the Xp21.3 region
12. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins
13. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
14. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
15. A new family of mouse genes homologous to the human MAGE genes
16. Identification of a new, unorthodox member of the MAGE gene family
17. A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin
18. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder
19. Expression of mage genes by non-small-cell lung carcinomas
20. Expression of MAGE genes in human colorectal carcinoma
21. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma
22. Expression of the MAGE gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy
23. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis
24. Carcinoma-in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma
25. Expression of MAGE genes in testicular germ cell tumors
26. MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors
27. Expression of MAGE-antigens in normal tissues and cancer
28. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells
29. Microwave antigen retrieval in immunocytochemistry: A study of 80 antibodies
30. MAGE-3 immunoreactivity in formalinfixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution
31. Identification and intracellular location of MAGE-3 gene product
32. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4
33. Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein
34. Wr1 gene expression in human testicular germ-cell tumors
35. Cytokeratin expression in seminoma of the human testis
36. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: Pathogenetic relevance
37. Immunohistochemical comparison between anaplastic seminoma and typical seminoma
38. Classical and anaplastic seminoma: Difference in survival
39. Mitosis counting in seminoma: An exercise of questionable significance
40. Contribution of cell proliferative activity to malignancy potential in testicular seminoma
41. Tumors of the testis, adnexa, spermatic cord, and scrotum
42. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours
43. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis
44. Stem cell factor/ckit system in spermatogenesis
45. Genetics and biology of adult human male germ cell tumors